Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses

International Immunology

Volumn 15, Issue 6, 2003, Pages 691-699

  López Díaz de Cerio, Ascensión ^a   Lasarte, Juan José ^a   Casares, Noelia ^a   Sarobe, Pablo ^a   Ruiz, Marta ^a   Prieto, Jesús ^a   Borrás Cuesta, Francisco ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Antibody; Antigen; Cytotoxicity; Epitope; Peptide; Th1; Th2; TCR

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; HAPTEN; INTERLEUKIN 4; MYOGLOBIN; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FAMILY; PROTEIN MODIFICATION; T LYMPHOCYTE ACTIVATION;

EID: 0037945068     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg071     Document Type: Article

References (53)

1. + T lymphocytes. Immunol. Today 9:268.
2. H1 clones. J. Immunol. 138:3688.
3. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
4. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
5. + T cell subset with an unrestricted cytokine profile. J. Immunol. 143:518.
6. Killar, L., MacDonald, G., West, J., Woods, A. and Bottomly, K. 1987. Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1 (BSF-1) fail to help antigen-specific B cells. J Immunol. 138:1674.
7. H2) T cell clones to activate effector function in macrophages. J. Immunol. 142:760.
8. H1 cells and antigen: responsiveness can be restored by IL-4. J. Immunol. 144:869.
9. Carballido, J. M., Carballido-Perrig, N., Terres, G., Heusser, C. H. and Blaser, K. 1992. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Eur. J. Immunol. 22:1357.
10. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:1579.
11. h2 differentiation is directly dependent on the dose of antigen. J. Immunol. 164:2955.
12. h2 cytokines. J. Immunol. 158:658.
13. h2 cells for contact hypersensitivity. J. Immunol. 159:4217.
14. De Becker, G., Moulin, V., Tielemans, F., De Mattia, F., Urbain, J., Leo, O. and Moser, M. 1998. Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur. J. Immunol. 28:3161.
15. h1-type immune responses requires the type I cytokine receptor TCCR. Nature 407:916.
16. + T cells. Annu. Rev. Immunol. 12:635.
17. h2 cytokines in protective immunity to nematodes. Immunol. Rev. 127:205.
18. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
19. Kumar, V., Bhardwaj, V., Soares, L., Alexander, J., Sette, A. and Sercarz, E. 1995. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. Proc. Natl Acad. Sci. USA 92:9510.
20. h-2 priming in vivo. J. Immunol. 157:3893.
21. Chaturvedi, P., Yu, Q., Southwood, S., Sette, A. and Singh, B. 1996. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int. Immunol. 8:745.
22. Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A. and Bottomly, K. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
23. + T cell differentiation. J. Immunol. 159:5956.
24. + T cells by antigenic peptides altered for TCR binding. J Immunol. 158:4237.
25. Buus, S., Colon, S., Smith, C., Freed, J. H., Miles, C. and Grey, H. M. 1986. Interaction between a 'processed' ovalbumin peptide and la molecules. Proc. Natl Acad. Sci. USA 83:3968.
26. Berkower, I., Kawamura, H., Matis, L. A. and Berzofsky, J. A. 1985. T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance. J. Immunol. 135:2628.
27. Shimonkevitz, R., Colon, S., Kappler, J. W., Marrack, P. and Grey, H. M. 1984. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol. 133:2067.
28. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8:319.
29. Berkower, I., Matis, L. A., Buckenmeyer, G. K., Gurd, F. R., Longo, D. L. and Berzofsky, J. A. 1984. Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones. J. Immunol. 132:1370.
30. h0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides. Int. Immunol. 11:2025.
31. Prieto, I., Hervas-Stubbs, S., Garcia-Granero, M., Berasain, C., Riezu-Boj, J. I., Lasarte, J. J., Sarobe, P., Prieto, J. and Borras-Cuesta, F. 1995. Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity. Eur. J. Immunol. 25:877.
32. Sarobe, P., Lasarte, J. J., Golvano, J., Gullon, A., Civeira, M. P., Prieto, J. and Borras-Cuesta, F. 1991. Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide. Eur. J. Immunol. 21:1555.
33. Lasarte, J. J., Sarobe, P., Gullon, A., Prieto, J. and Borras Cuesta, F. 1992. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell. Immunol. 141:211.
34. Widmann, C., Romero, P., Maryanski, J. L., Corradin, G. and Valmori, D. 1992. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria pepticles. J. Immunol. Methods 155:95.
35. Valmori, D., Romero, J. F., Men, Y., Maryanski, J. L., Romero, P. and Corradin, G. 1994. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 24:1458.
36. + T lymphocytes induced by peptide immunization: an ex vivo analysis. Int. Immunol. 10: 1273.
37. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149.
38. Borras Cuesta, F., Golvano, J., Sarobe, P., Lasarte, J. J., Prieto, I., Szabo, A., Guillaume, J. L. and Guillet, J. G. 1991. Insights on the amino acid side-chain interactions of a synthetic T-cell determinant. Biologicals 19:187.
39. Shirai, M., Akatsuka, T., Pendleton, C. D., Houghten, R., Wychowski, C., Mihalik, K., Feinstone, S. and Berzofsky, J. A. 1992. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 66:4098.
40. van der Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M. and Ahmed, R. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543.
41. h1 helper peptide elicits protective CTL immunity. Eur. J. Immunol. 31:1780.
42. Shirai, M., Arichi, T., Nishioka, M., Nomura, T., Ikeda, K., Kawanishi, K., Engelhard, V. H., Feinstone, S. M. and Berzofsky, J. A. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733.
43. Kersh, G. J., Miley, M. J., Nelson, C. A., Grakoui, A., Horvath, S., Donermeyer, D. L., Kappler, J., Allen, P. M. and Fremont, D. H. 2001. Structural and functional consequences of altering a peptide MHC anchor residue. J. Immunol. 166:3345.
44. Thomson, C. T., Kalergis, A. M., Sacchettini, J. C. and Nathenson, S. G. 2001. A structural difference limited to one residue of the antigenic peptide can profoundly alter the biological outcome of the TCR-peptide/MHC class I interaction. J. Immunol. 166:3994.
45. Davis, M. M. and Bjorkman, P. J. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395.
46. Sette, A., Buus, S., Colon, S., Smith, J. A., Miles, C. and Grey, H. M. 1987. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328:395.
47. Singh, J. and Thornton, J. M. 1992. Atlas of Protein Side-Chain Interactions. IRL Press, Oxford.
48. Slansky, J. E., Rattis, F. M., Boyd, L. F., Fahmy, T., Jaffee, E. M., Schneck, J. P., Margulies, D. H. and Pardoll, D. M. 2000. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity 13:529.
49. + T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen. J. Immunol. 168:3242.
50. h2 cytokine balance. J. Immunol. 163:1205.
51. Robertson, J. M., Jensen, P. E. and Evavold, B. D. 2000. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 164:4706.
52. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J. Immunol. 165:3136.
53. Alexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H. M., Kubo, R. T., Sette, A. and Grey, H. M. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1:751.